Recent achievements in CAR-T cell immunotherapy for glioblastoma treatment

Glioblastoma remains the most common and aggressive primary brain tumor today. Because of the neuroanatomical location of glioblastoma, conventional chemotherapy and radiation therapy have limited efficacy in patients with these tumors. Over the past decade, antitumor immunotherapy has become widesp...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: S. V. Timofeeva, A. O. Sitkovskaya, I. A. Novikova, M. A. Ezhova, E. P. Lysenko, O. I. Kit
Format: article
Langue:RU
Publié: SPb RAACI 2021
Sujets:
Accès en ligne:https://doaj.org/article/bc84923f84924863a08fac30e16a46d8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!